MOHW is still in dilemma to implement the controversial referential pricing system

Published: 2002-05-13 07:00:00

Updated: 2002-05-13 07:00:00

Informed sources that the Ministry of Health and Welfare (MOHUW) has yet to decide the enforcement date of the referential pricing system designed to discourage the prescription of high-priced drugs, due to the effectiveness of such system.

Vowing to reduce the increasing drug charges for bet...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK